A 2 week run in period with placebo was initiated for all patients at this time, and the patients antihypertensive regimens were standardized to the preferred regimens within each drug class as follows lisinopril 20 to 40 mg daily was given in place of an angiotensin converting enzyme inhibitor, losartan 50 to 100 mg daily was given in place of an angiotensi